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In Practice
Assessment and management of diabetic 
ulcers in the primary health care setting
Case scenario
John is a 62 year old gentleman who has been suffering from 
type 2 Diabetes Mellitus for the past 7 years.  He presents to 
the clinic with an ulcer 5 mm in diameter on the lateral aspect 
of the right foot near the metatarsophalangeal joint area.  The 
ulcer is just involving the epidermis, appears dry and is not 
erythematous.  It has developed two days ago after wearing a 
new pair of shoes for 10 days.  He is currently on metformin 
500mg tds and gliclazide 80mg daily.  
Introduction
Diabetic patients presenting with skin lesions and ulcers 
need urgent assessment and intervention because the vast 
majority of diabetic foot complications resulting in amputation 
begin with the development of skin ulcers. The prompt and 
aggressive treatment of diabetic foot ulcers can often prevent 
exacerbation of the problem and eliminate the potential for 
amputation.1,2 This will allow prompt healing of the lesion 
and prevent recurrence once it has healed. Multidisciplinary 
management programmes that focus on education, prevention, 
regular foot examinations, aggressive intervention, and optimal 
use of therapeutic footwear have demonstrated significant 
reductions in the incidence of lower-extremity amputations.3,4
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Initial assessment
When a patient presents with an ulcer, the initial assessment 
should aim to determine the cause of the ulcer. The main causes 
of ulcers in diabetics are due to neuropathy, ischaemia, or a 
combination of both. Inappropriate footwear (as in this case), 
or foot deformities can lead to pressure areas which are prone 
to ulceration. Therefore, a meticulous history and a proper 
examination are of vital importance.  
History taking
In the presence of an ulcer, the patient should be questioned 
about the presence of pain in the ulcer itself and in the lower 
limbs. The presence of pain in the ulcer may denote ischaemia 
or an infective process. If pain is present in the lower limbs, 
further enquiry is needed to determine whether this is due to 
a neuropathy or due to claudication as a result of peripheral 
vascular disease.
The diabetic control of the patient is of utmost importance. 
The results of previous HbA1c levels will help determine this.
A history of smoking, hypertension and hyperlipidaemia are 
three risk factors that should be looked into. These commonly 
contribute to the increased prevalence of peripheral arterial 
occlusive disease in diabetics.5 The presence of microvascular 
and macrovascular complications of diabetes (like retinopathy, 
nephropathy, neuropathy, cardiovascular and cerebrovascular 
complications) must also be elicited. 
The medications the patient is taking are also important. 
For example, Beta-adrenergic blocking drugs have previously 
been discouraged in peripheral arterial disease because of the 
possibility of worsening claudication symptoms. However, this 
concern has not been borne out by randomised trials; therefore, 
beta-adrenergic-blocking drugs can be safely utilised in patients 
with claudication.6 In particular, patients with peripheral arterial 
disease who also have concomitant coronary disease may have 
additional cardioprotection with beta-adrenergic-blocking 
agents.7
Footwear habits, like barefoot walking or the purchase of 
new footwear which was either tight or loose fitting, have also 
to be enquired about.  New footwear was in fact the cause of the 
ulcer in the patient discussed here and, if this issue is overlooked, 
the results might not be successful. The usage of proper socks, 
which preferably have to be worn inside out to prevent the 
sewing line from causing pressure to the foot, has to be checked. 
Scald injuries could also have been the cause and so one should 
ask for example about the use of hot water bottles.
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Physical examination
Physical examination of the extremity having a diabetic ulcer 
can be divided into 3 broad categories: 
1. Examination of the ulcer and general condition of the 
extremity
2. Assessment for the presence of vascular insufficiency
3. Assessment for the presence of peripheral neuropathy. 
Visual inspection is necessary to check for deformities 
leading to pressure points, callus formation, cellulitis, fungal 
infections, dry skin, and fissures. Thin or shiny skin and the 
absence of hair may denote an element of ischaemia. Thickened 
nails or badly cut nails may be causing harm. One must also 
check carefully between the toes since fungal infections may 
be present there. It is also important to inspect the footwear 
for poor fit, rough areas, or worn out parts which are causing 
pressure.
An adequate description of ulcer characteristics, such as 
size, depth, appearance, and location should be done (as has 
been described in the above case). This will be essential for the 
mapping of progress during treatment.8 Gentle probing can 
detect sinus tract formation, undermining of ulcer margins, and 
dissection of the ulcer into tendon sheaths, bone, or joints. The 
existence of odour and exudate, and the presence and extent of 
cellulitis must also be noted.
  Classification of ulcerations can facilitate a logical approach 
to treatment and aid in the prediction of outcome. Several 
wound classification systems have been created. The most widely 
accepted classification system for diabetic foot ulcers and lesions 
is the Wagner ulcer classification system (Table 1), which is 
based on the depth of penetration, the presence of osteomyelitis 
or gangrene, and the extent of tissue necrosis.9  
The University of Texas diabetic wound classification system 
(Table 2) assesses the depth of ulcer penetration, the presence 
of wound infection, and the presence of clinical signs of lower-
extremity ischemia.10 This system uses four grades of ulcer 
depth (0 to III) and four stages (A to D), based on ischaemia or 
infection, or both. The University of Texas system is generally 
Table 1: Wagner Classification of Diabetic Foot Ulcers
Grade 0: No ulcer in a high risk foot
Grade : Superficial ulcer involving the full skin 
thickness but not underlying tissues
Grade 2: Deep ulcer, penetrating down to ligaments 
and muscle, but no bone involvement        
               or abscess formation
Grade : Deep ulcer with cellulitis or abscess 
formation, often with osteomyelitis
Grade 4:  Localised gangrene
Grade :  Extensive gangrene involving the whole foot
predictive of outcome, because wounds of increasing grade 
and stage are less likely to heal without revascularization or 
amputation.10
The adequacy of the blood supply of the lower limb must also 
be determined. Peripheral arterial occlusive disease is four times 
more prevalent in diabetics than in nondiabetics.11 All lower 
limb pulses should be checked. The foot is also examined for 
capillary return in the nail bed and pallor on elevating the foot. 
Ankle-brachial index determinations using a Doppler are very 
important. Subjective assessment of peripheral pulses, especially 
in diabetics, is often unreliable and the ankle-brachial index will 
give an objective assessment of the situation. An index less than 
0.80 is abnormal, and if it is less than 0.45 it is severe and limb-
threatening. Further investigations by the vascular surgeon, like 
angiography, will then be necessary. Vascular status must always 
be assessed because ischaemia portends a poor prognosis for 
healing without vascular intervention.  
Neuropathy is a major aetiologic component of most diabetic 
ulcerations and is present in more than 82% of diabetic patients 
with foot wounds.12 Failure to perceive the pressure of a 10-g 
monofilament is a proven indicator of peripheral sensory 
neuropathy and loss of protective sensation.13 Other common 
modalities that can detect insensitivity are a standard tuning 
fork (128Hz) and a neurologic reflex hammer.
One must keep in mind that diabetes is a systemic disease. 
Hence, a comprehensive physical examination of the entire 
patient is also vital. During such a visit, the patient has also to be 
checked for other complications of diabetes. The cardiovascular 
system should be assessed to include BMI, waist circumference, 
and blood pressure. A fundoscopy should always be done in 
order to check for signs of diabetic retinopathy. Lipid levels, 
and HbA1c should also be arranged if the patient has defaulted 
from his/her regular follow-up. Serum creatinine and urinalysis 
for micro-albuminuria should be done to assess the kidney. 
Liver function tests are also important since nonalcoholic 
steatohepatitis is seen more frequently in diabetic patients.14
Short-term management
The management of diabetic ulcers needs a multidisciplinary 
approach. The doctor responsible for the patient’s care has to 
liaise with podiatrists and the foot care clinic, the Tissue Viability 
Unit, and with a vascular surgeon. Effective care involves a 
partnership between patients and professionals, and all decision 
making should be shared.  Multidisciplinary management 
programmes that focus on patient education and empowerment, 
regular foot examinations, aggressive intervention, and optimal 
use of therapeutic footwear have demonstrated significant 
reductions in the incidence of lower-extremity amputations.3,4 
Rest and relief of pressure are essential components of 
treatment and should be initiated at first presentation. In this 
particular instance, the ill-fitting footwear should be replaced. 
Crutches or a wheelchair can also be recommended to totally 
off-load pressure from the foot. Although total contact casting 
(TCC) is considered the optimal method of management for 
neuropathic ulcers, it must be reapplied weekly and requires 
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considerable experience to avoid iatrogenic lesions. Acceptable 
alternatives to TCC are removable walking braces and orthotic 
devices like the “half shoe”.
One has to initiate and supervise wound management with 
regular follow up. Although numerous topical medications and 
gels are promoted for ulcer care, relatively few have proven to 
be more efficacious than saline wet-to-dry dressings.8 Topical 
antiseptics, such as povidone-iodine, are usually considered 
to be toxic to healing wounds.8  Generally, a warm, moist 
environment that is protected from external contamination is 
most conducive to wound healing. This can be provided by a 
number of commercially available special dressings, including 
semipermeable films, foams, hydrocolloids, and calcium alginate 
swabs.15 Table 3 below gives some examples.
The patient presented in this article in fact did very well 
with a hydrocolloid dressing and replacement of the ill-fitting 
new shoe. Should there be necrotic, callus, or fibrous tissue it 
should be debrided once adequate perfusion of the limb has been 
confirmed.8 Unhealthy tissue must be sharply debrided back 
to bleeding tissue to allow full visualisation of the extent of the 
ulcer and detect underlying abscesses or sinuses. Soaking ulcers 
is controversial and should be avoided because the neuropathic 
patient can easily be scalded by hot water.8  Currently, there is 
lack of trial evidence on the use of the following interventions 
in the treatment of foot ulcers and they are not recommended: 
cultured human dermis (or equivalent), hyperbaric oxygen 
therapy, topical ketanserin or growth factors.16
Vascular surgery consultation for possible revascularization 
should be sought when clinical signs of ischaemia are present or 
when there is no access to objective assessment of the perfusion 
of the limb. Prompt referral is important in those who may 
benefit from revascularisation.  
Table 2: University of Texas Wound Classification System of Diabetic Foot Ulcers
Grade 0-A: Pre or post-ulcerative lesion completely epithelialised
Grade 0-A: Pre or post-ulcerative lesion completely epithelialised, with infection
Grade 0-A: Pre or post-ulcerative lesion completely epithelialised, with ischaemia
Grade 0-A:  Pre or post-ulcerative lesion completely epithelialised, with infection and ischaemia
Grade I-A:  Non-infected, non-ischemic superficial ulceration
Grade I-B:  Infected, non-ischemic superficial ulceration
Grade I-C:  Ischaemic, non-infected superficial ulceration
Grade I-D: Ischaemic and infected superficial ulceration
 
Grade II-A:  Non-infected, non-ischaemic ulcer that penetrates to capsule or bone
Grade II-B:  Infected, non-ischaemic ulcer that penetrates to capsule or bone
Grade II-C:  Ischaemic, non-infected ulcer that penetrates to capsule or bone
Grade II-D:  Ischaemic and infected ulcer that penetrates to capsule or bone
 
Grade III-A:  Non-infected, non-ischaemic ulcer that penetrates to bone or a deep abscess
Grade III-B:  Infected, non-ischaemic ulcer that penetrates to bone or a deep abscess
Grade III-C:  Ischaemic, non-infected ulcer that penetrates to bone or a deep abscess
Grade III-D:  Ischaemic and infected ulcer that penetrates to bone or a deep abscess
Aspirin should be started if the patient is not already 
on it, unless there are contraindications to its use. In that 
case adenosine diphosphate (ADP) receptor inhibitors like 
clopidrogel or ticlopidine may be used. In non-critical peripheral 
ischaemia, there is no indication for warfarin treatment as 
the complexities of management and bleeding risks seem to 
far outweigh the benefits, unless the patient has concomitant 
problems needing anticoagulation such as atrial fibrillation.17 
Statins should also be started.18
Deep or longstanding ulcers may need radiographic 
examination to check for osteomyelitis.
One should be careful about the following signs and 
symptoms and hence one must also instruct the patient to watch 
out for these changes as well in order to detect any deterioration 
immediately.
•	 Changes in the ulcer, like increase in size or change in 
colour.
•	 Redness of the skin around the ulcer, or the skin going 
black.
•	 New-onset of discharge from the ulcer. 
•	 When this happens, one should take cultures from the 
purulent drainage or curetted material from the ulcer 
base. When infection is present, aerobic and anaerobic 
cultures should be obtained, followed by initiation 
of appropriate broad-spectrum antibiotic therapy.8 
Antibiotic coverage should subsequently be tailored 
according to the clinical response of the patient, culture 
results, and sensitivity testing. If the cellulitis progresses 
to a moderate state the patient has to be referred for 
inpatient treatment.
•	 Development of new ulcers or blistering.
2 Malta Medical Journal    Volume 20   Issue 04   December 2008
Alginate
Examples: AlgiSite, Comfeel, Curasorb, Kaltogel, 
Kaltostat, Sorbsan, Tegagel
Description: This seaweed extract contains guluronic and 
mannuronic acids that provide tensile strength and calcium 
and sodium alginates, which confer an absorptive capacity. 
Some of these can leave fibers in the wound if they are not 
thoroughly irrigated. These are secured with secondary 
coverage. 
Applications: These are highly absorbent and useful 
for wounds having copious exudate. Alginate rope is 
particularly useful to pack exudative wound cavities or 
sinus tracts.
Hydrofiber
Examples: Aquacel, Aquacel-Ag, Versiva
Description: An absorptive textile fibre pad, also 
available as a ribbon for packing of deep wounds. This 
material is covered with a secondary dressing. The 
hydrofibre combines with wound exudate to produce a 
hydrophilic gel. Aquacel-Ag contains 1.2% ionic silver 
that has strong antimicrobial properties against many 
organisms, including methicillin-resistant Staphylococcus 
aureus and vancomycin-resistant Enterococcus.
Applications: Thesve are absorbent dressings used for 
exudative wounds.
Debriding agents
Examples: Hypergel (hypertonic saline gel), Santyl 
(collagenase), Accuzyme (papain urea)
Description: Various products provide some degree of 
chemical or enzymatic debridement.
Applications: These are useful for necrotic wounds as an 
adjunct to surgical debridement.
Foam
Examples: LYOfoam, Spyrosorb, Allevyn
Description: Polyurethane foam has some absorptive 
capacity.
Applications: These are useful for cleaning granulating 
wounds having minimal exudate.
Table 3: Characteristics and uses of Wound Dressing Materials
Hydrocolloid
Examples: Aquacel, CombiDERM, Comfeel, Duoderm 
CGF Extra Thin, Granuflex, Tegasorb
Description: These are made of microgranular 
suspension of natural or synthetic polymers, such as 
gelatin or pectin, in an adhesive matrix. The granules 
change from a semihydrated state to a gel as the wound 
exudate is absorbed.
Applications: They are useful for dry necrotic wounds, 
wounds having minimal exudate, and clean granulating 
wounds.
Hydrogel
Examples: Aquasorb, Duoderm, IntraSite Gel, Granugel, 
Normlgel, Nu-Gel, Purilon Gel, (KY jelly)
Description: These are water-based or glycerin-based 
semipermeable hydrophilic polymers; cooling properties 
may decrease wound pain. These gels can lose or absorb 
water depending upon the state of hydration of the wound. 
They are secured with secondary covering.
Applications: These are useful for dry, sloughy, necrotic 
wounds (eschar).
Low-adherence dressing 
Examples: Mepore, Skintact, Release
Description: These are various materials designed to 
remove easily without damaging underlying skin.
Applications: These are useful for acute minor wounds, 
such as skin tears, or as a final dressing for chronic wounds 
that have nearly healed.
Transparent film
Examples: OpSite, Skintact, Release, Tegaderm, 
Bioclusive 
Description: These are highly conformable acrylic 
adhesive film having no absorptive capacity and little 
hydrating ability, and they may be vapour permeable or 
perforated. 
Applications: These are useful for clean dry wounds 
having minimal exudate, and they also are used to secure 
an underlying absorptive material. They are used for 
protection of high-friction areas and areas that are difficult 
to bandage such as heels (also used to secure IV catheters).
Adapted from Stillman RM. Wound Care. eMedicine August 19, 2008. http://www.emedicine.com/MED/topic2754.htm
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•	 Ulcer becoming painful or uncomfortable.  This might 
mean it is getting infected and prompt treatment has to 
be initiated.
•	 Any new smell from the ulcer may also indicate that it is 
getting infected.
•	 Any new swelling.  This might cause further problems 
like for example the shoe now may become tight and thus 
cause a new ulcer.
•	 Development of fever may denote that the ulcer is now 
infected.
Initial empirical antibiotic therapy of an infected ulcer 
should be with flucloxacillin, co-amoxiclav, or clindamycin.19 
The antibiotic is then changed according to the culture results. 
Antibiotic treatment should be given for at least 7 to 14 days in 
infections that appear to be localized.19 Patients with non-healing 
or progressive ulcers with clinical signs of active infection 
(redness, pain, swelling or discharge) despite appropriate oral 
antibiotic treatment should be referred to receive intensive, 
systemic antibiotic therapy.
Prevention
All diabetic patients should be taught about self-care and 
self monitoring of their feet.  Daily self-examination of the feet 
should be carried out to look out for colour changes, swelling, 
and breaks in the skin. If mobility is limited, one can use mirrors 
for self-examination. Any new pain or numbness has to be 
reported to the family doctor.  Footwear should be well-fitting 
and appropriate socks should be worn. Some patients would 
need insoles or special shoes if they have any deformities and so 
should be referred appropriately. No barefoot walking is allowed. 
The need of proper hygiene with daily washing and careful 
drying should also be emphasized. Nail care, and the dangers 
of corn removal should be highlighted and regular attendance 
at a podiatrist should be encouraged. The patients who have 
neuropathic feet also have to be educated regarding the dangers 
of hot water, electric blankets, hot water bottles, and similar 
threats to pain-insensitive feet, which can be easily scalded 
without the patient even noticing. Dry skin should be treated by 
regular application of moisturising agents and emollients. The 
patients have to be educated so that they immediately consult 
their family doctor should any skin wound develop.
One also has to try to achieve optimal glucose control and 
also control the risk factors for cardiovascular disease (like 
hypertension, hyperlipidaemia and obesity). If the patient is 
a smoker, smoking cessation is essential for preventing the 
progression of occlusive disease. Microvascular complications 
have also to be kept in mind and the patients have to be 
assessed for retinopathy, nephropathy, and other symptoms 
of neuropathy (like altered bowel habits). Liaison with other 
specialists is also important in this field.
The patients need to be recalled and reviewed as part of their 
ongoing diabetic care.  Their feet have to be checked at every visit.  One 
must also ensure that they are being seen regularly by a podiatrist in 
order to prevent and catch problems at an early stage.
Conclusion
Lower limb ulcers are common in patients with diabetes. 
Appropriate assessment and management will lead to good 
results and avoidance of complications as happened in this 
patient. If treatment is delayed or inappropriate treatment is 
rendered, the lesion can become infected, resulting in gangrene 
and/or amputation. Multidisciplinary management is of prime 
importance and should tackle patient education, regular 
foot examinations, optimal diabetic control and aggressive 
interventions when necessary.  
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